Delivery Order SPE2DB22D1202-SPE2DB24FUVE3
Award Date 3/28/24
Potential Completion Date 3/29/24
Potential Value $35K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of Dupixent 300 mg/2 ml syringes. The award, valued at $1,652.35, has an ultimate completion date of April 15, 2024. The contract is not associated with any set-aside designations. Amerisourcebergen Drug Corp, through its Corporate Office division located in Conshohocken, Pennsylvania, is the prime contractor. This...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division for the supply of Dupixent 300 mg/2 ml syringes. The fixed-price contract, valued at $13,095.42, has a completion date of September 18, 2023. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $14,937.00 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the procurement of 4,564,110,516 units of the pharmaceutical product Dupixent 300 mg/2 ml Syringe (2 ml). The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 and with a performance period through December 31, 2025....
- The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Dupixent 300 mg/2 ml syringes. The contract, valued at $23,211.99, has an ultimate completion date of June 7, 2022. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) awarded by DLA with a potential value of $999,999,999.00 and a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Dupixent 200 mg/1.14 ml syringes. The $26,114.32 contract has a period of performance through March 18, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite delivery contract with DLA Troop Support Medical to deliver a range of pharmaceutical products and...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $3,304.72 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,119,552 units of the pharmaceutical product Dupixent 300 mg/2 ml syringe. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 and with a performance period through December 31, 2025. The IDC serves as the...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to supply Dupixent 300 mg/2 ml syringes. The $6,407.20 firm fixed-price contract has a completion date of July 8, 2024. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical, which enables the agency to efficiently procure a range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of Dupixent 300 mg/2 ml syringes. The order, valued at $10,387.04, will support military treatment programs and facilities through March 2024. This award is part of a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance period through...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 mL syringes. The $3,304.70 fixed-price delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999 through December 2025, which enables the DLA to procure a wide range of medical commodities from Amerisourcebergen. This delivery order does not have a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,957.42 to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Dupixent 300 mg/2 mL syringes. This non-competitive delivery order, with a firm fixed price structure, represents a child contract against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The product will be delivered to AmerisourceBergen's...